ResMed Inc. stock rises Friday, outperforms market
Shares of ResMed Inc. RMD rose 1.12% to $239.78 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.00% to 5,996.66 and the ...
ResMed Inc. stock rises Thursday, outperforms market
Shares of ResMed Inc. RMD rallied 1.61% to $237.13 Thursday, on what proved to be an all-around poor trading session for the ...
Goldman Sachs tips ResMed shares to rocket 30% to a record high
The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...
Goldman Sachs starts coverage on ResMed with "buy" rating
Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.
ResMed initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of ResMed (RMD) with a Buy rating and A$48.90 price target The firm says its Buy thesis is based on “robust” ...
Best Sleep Setups for Sleep Apnea, Acid Reflux, Asthma, and Allergies
Expert advice to help make bedtime more comfortable instead of a challengeBy Danielle ClaroPunching the pillows, flipping ...